The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Abstract
After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [149]
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [55]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation
Research works printed but not linked: 13
- Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
- Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
- Powell S. N., et al., Cancer Res. 55, 1643 (1995);
- Fan S., et al., Cancer Res. 55, 1649 (1995);
- Russell K. J., et al., ibid. 55, 1639 (1995).
- Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
- Michieli P., et al., Cancer Res. 54, 3391 (1994);
- Paules R. S., et al., Cancer Res 55, 1763 (1995);
- Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
- Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
- Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
- El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
- Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);
Cited by
Sorted by citations
Items 801–900 of 1,018
Yu, M., Zhan, Q., & Finn, O. J. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00026-3 · Cited by 74
Molecular aspects of esophageal squamous cell carcinoma carcinogenesis
Lehrbach, D. M., Nita, M. E., & Cecconello, I. (2003) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032003000400011 · Cited by 73
Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines
Matkar, S. S., Wrischnik, L. A., & Hellmann‐Blumberg, U. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.12.006 · Cited by 73
iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe
Jiang, L., Siu, M. K. Y., Wong, O. G., Tam, K.-F., Lü, X., Lam, E. W. ‐., Ngan, H., Le, X., Wong, E. S. Y., Monteiro, L. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0588 · Cited by 75
Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
Hahne, J. C., & Valeri, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00226 · Cited by 74
Transcription Factor Yin Yang 1 Stimulates Poly(ADP-Ribosyl)ation and DNA Repair
Oei, S. L., & Shi, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4985 · Cited by 73
Gene Targeting in Human Cells Without Isogenic DNA
Sedivy, J. M., Vogelstein, B., Liber, H. L., Hendrickson, E. A., & Rosmarin, A. G. (1999) · Science · doi:10.1126/science.283.5398.9a · Cited by 73
Self-citationProgress in cancer genetics: Lessons from pancreatic cancer
Goggins, M., Kern, S. E., Offerhaus, J. G. A., & Hruban, R. H. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s4 · Cited by 75
Cell Cycle Checkpoint Function in Bladder Cancer
Doherty, S. C., McKEOWN, S. R., McKelvey‐Martin, V. J., Downes, C. S., Atala, A., Yoo, J. J., Simpson, D. A., & Kaufmann, W. K. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg120 · Cited by 73
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo, N., Faller, D. V., & Vaziri, C. (2002) · PubMed · Cited by 73
Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72
Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2
Xu, R., Garcı́a-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 73
p53: From Fundamental Biology to Clinical Applications in Cancer
Capuozzo, M., Santorsola, M., Bocchetti, M., Perri, F., Cascella, M., Granata, V., Celotto, V., Gualillo, O., Cossu, A. M., Nasti, G., et al. (2022) · Biology · doi:10.3390/biology11091325 · Cited by 74
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis.
Lee, C., Blum, J. M., & Kirsch, D. G. (2013) · PubMed · Cited by 72
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
Klein, D. K., Hoffmann, S., Ahlskog, J. K., O’Hanlon, K. A., Quaas, M., Larsen, B. D., Rolland, B., Rösner, H. I., Walter, D., Kousholt, A. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms6800 · Cited by 72
Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis
Imreh, G., Norberg, H. V., Imreh, S., & Zhivotovsky, B. (2011) · Journal of Cell Science · doi:10.1242/jcs.081612 · Cited by 72
Tao, Y., Zhang, P., Frascogna, V., Lécluse, Y., Auperin, A., Bourhis, J., & Deutsch, É. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604083 · Cited by 72
Wild-type p53 and p73 negatively regulate expression of proliferation related genes
Scian, M. J., Carchman, E. H., Mohanraj, L., Stagliano, K. E., Anderson, M. A. E., Deb, D., Crane, B., Kiyono, T., Windle, B. E., Deb, S., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210898 · Cited by 73
Campregher, C., Luciani, M. G., & Gasché, C. (2008) · Gut · doi:10.1136/gut.2007.141556 · Cited by 75
Huang, B., Deo, D. D., Xia, M., & Vassilev, L. T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0144 · Cited by 73
α-amino trimethylation of CENP-A by NRMT is required for full recruitment of the centromere
Sathyan, K. M., Fachinetti, D., & Foltz, D. R. (2017) · Nature Communications · doi:10.1038/ncomms14678 · Cited by 72
Niu, F., Yan, J., Ma, B., Li, S., Shao, Y., He, P., Zhang, W., He, W., Ma, P. X., & Lu, W. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.025 · Cited by 72
WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation
Idelman, G., Glaser, T., Roberts, C. T., & Werner, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211606200 · Cited by 72
Bao, S., Lu, T., Wang, X. A., Zheng, H., Wang, L., Wei, Q., Hittelman, W. N., & Li, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207753 · Cited by 72
The molecular control of DNA damage-induced cell death
Coultas, L., & Strasser, A. (2000) · APOPTOSIS · doi:10.1023/a:1009617727938 · Cited by 72
Fung, H., & Demple, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146498 · Cited by 71
Chen, W.-Y., Wu, C., Lan, Y., Chang, F., Teng, C., & Wu, Y. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.047 · Cited by 71
Wendt, J., Radetzki, S., von Haefen, C., Hemmati, P., Güner, D., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1209031 · Cited by 71
Kamei, J., Toyofuku, T., & Hori, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.129 · Cited by 71
Wu, P., Hong, S., Veeranki, S., Karkhanis, M. S., Starenki, D., Plaza, J. A., & Park, J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00021-13 · Cited by 71
Checkpoint adaptation in human cells
Syljuåsen, R. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210402 · Cited by 78
Jeffy, B. D., Chen, E. J., Gudas, J. M., & Romagnolo, D. F. (2000) · Neoplasia · doi:10.1038/sj.neo.7900104 · Cited by 71
Adimoolam, S., Lin, C., & Ford, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102240200 · Cited by 71
Models of reactive oxygen species in cancer
Lu, W., Ogasawara, M. A., & Huang, P. (2007) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2007.10.005 · Cited by 72
Wanka, C., Brucker, D. P., Bähr, O., Ronellenfitsch, M. W., Weller, M., Steinbach, J. P., & Rieger, J. (2011) · Oncogene · doi:10.1038/onc.2011.530 · Cited by 73
Wiebusch, L., & Hagemeier, C. (2010) · Oncogene · doi:10.1038/onc.2010.99 · Cited by 72
Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells
Taylor, W. R., Fedorka, S. R., Gad, I., Shah, R. V., Alqahtani, H. D., Koranne, R., Kuganesan, N., Dlamini, S., Rogers, T., Al-Hamashi, A. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42251-5 · Cited by 71
Asher, G., Lotem, J., Tsvetkov, P., Reiss, V., Sachs, L., & Shaul, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436329100 · Cited by 70
Polager, S., & Ginsberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210327200 · Cited by 70
Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer
Liu, K., Bellam, N., Lin, H., Wang, B., Stockard, C. R., Grizzle, W. E., & Lin, W.-C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01140-08 · Cited by 70
Critical Role for Mouse Hus1 in an S-Phase DNA Damage Cell Cycle Checkpoint
Weiss, R. S., Leder, P., & Vaziri, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.791-803.2003 · Cited by 71
Orre, L. M., Pernemalm, M., Lengqvist, J., Lewensohn, R., & Lehtiö, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700202-mcp200 · Cited by 70
Park, H. U., Jeong, J., Chung, J. H., & Brady, J. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207644 · Cited by 74
Yun, U. J., Park, S. E., Jo, Y. S., Kim, J., & Shin, D. Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.003 · Cited by 69
The Structure of the Human Cell Cycle
Stallaert, W., Kedziora, K. M., Taylor, C. D., Zikry, T. M., Ranek, J. S., Sobon, H. K., Taylor, S. R., Young, C. L., Cook, J. G., & Purvis, J. E. (2021) · Cell Systems · doi:10.1016/j.cels.2021.10.007 · Cited by 80
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium
Moding, E. J., Lee, C., Castle, K. D., Oh, P., Mao, L., Zha, S., Min, H. D., Ma, Y., Das, S. K., & Kirsch, D. G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73932 · Cited by 73
A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation
Jiang, P., Du, W., & Yang, X. (2013) · Cell Cycle · doi:10.4161/cc.27267 · Cited by 71
Visanji, J. M., Thompson, D. G., Padfield, P. J., Duthie, S. J., & Pirie, L. P. (2004) · Journal of Nutrition · doi:10.1093/jn/134.11.3121 · Cited by 69
Roles of p53 and Caspases in the Induction of Cell Cycle Arrest and Apoptosis by HIV-1 vpr
Shostak, L. D., Ludlow, J. W., Fisk, J., Pursell, S., Rimel, B. J., Nguyen, D. X., Rosenblatt, J. D., & Planelles, V. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4568 · Cited by 69
DNA Damage Triggers p21WAF1-dependent Emi1 Down-Regulation That Maintains G2 Arrest
Lee, J., Kim, J. A., Barbier, V., Fotedar, A., & Fotedar, R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0818 · Cited by 68
Becker, J. A. J., Mirjolet, J.-F., Bernard, J., Burgeon, E., Simons, M.-J., Vassart, G., Parmentier, M., & Libert, F. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.094 · Cited by 69
Chetty, C., Bhoopathi, P., Rao, J. S., & Lakka, S. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24209 · Cited by 68
Blanch, A., Robinson, F., Watson, I. R., Cheng, L. S., & Irwin, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066436 · Cited by 68
Clark, E., Santiago, F., Deng, L., Chong, S. Y., de la Fuente, C., Wang, L., Fu, P., Stein, D., Denny, T. N., Lanka, V. K., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5040-5052.2000 · Cited by 68
Pereira, L. P., Silva, P., Duarte, M., Rodrigues, L. A., Duarte, C. M. M., Albuquerque, C. M., & Serra, T. (2017) · Nutrients · doi:10.3390/nu9040368 · Cited by 70
OʼDonnell, R. T., DeNardo, S. J., Miers, L. A., Lamborn, K. R., Kukis, D. L., DeNardo, G. L., & Meyers, F. J. (2001) · The Prostate · doi:10.1002/pros.10029 · Cited by 68
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., & Sedivy, J. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2859-2870.2003 · Cited by 68
Self-citationSchwartz, D., Goldfinger, N., Kam, Z., & Rotter, V. (1999) · PubMed · Cited by 68
Protein Kinase D as a Potential Chemotherapeutic Target for Colorectal Cancer
Wei, N., Chu, E., Wipf, P., & Schmitz, J. C. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0880 · Cited by 67
Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response
Nantajit, D., Fan, M., Duru, N., Wen, Y., Reed, J. C., & Li, J. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012341 · Cited by 68
Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement
af Hällström, T., Jäämaa, S., Mönkkönen, M., Peltonen, K., Andersson, L. C., Medema, R. H., Peehl, D. M., & Laiho, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609299104 · Cited by 68
Human tumor suppressor p53 and DNA viruses
Collot-Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 69
Synthesis and evaluation of spiroisoxazoline oxindoles as anticancer agents
Ribeiro, C. J. A., Amaral, J. D., Rodrigues, C. M. P., Moreira, R., & Santos, M. M. M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.048 · Cited by 67
Zhu, N., Shao, Y., Xu, L., Yu, L., & Sun, L. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9419-9 · Cited by 67
Chae, H.-D., Yun, J., Bang, Y., & Shin, D. Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207482 · Cited by 67
Hayward, R. L., Macpherson, J. S., Cummings, J., Monia, B. P., Smyth, J. F., & Jodrell, D. I. (2003) · PubMed · Cited by 67
Endlich, B., Radford, I. R., Forrester, H. B., & Dewey, W. C. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0036:cvtlms]2.0.co;2 · Cited by 66
Malonia, S. K., Dutta, P., Santra, M. K., & Green, M. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510929112 · Cited by 66
Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U. M., Mignotte, B., Floch, N. L., Vayssière, J., & Rincheval, V. (2013) · Cell Cycle · doi:10.4161/cc.25870 · Cited by 74
Rao, B., Laı́n, S., & Thompson, A. M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.702 · Cited by 66
Andrysík, Z., Kim, J., Tan, A. C., & Espinosa, J. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.014 · Cited by 68
Clastogenicity of the fungicide afugan in cultured human lymphocytes
Yüzbaşıoğlu, D., Çelık, M., Yılmaz, S., Ünal, F. Ş., & Aksoy, H. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.01.001 · Cited by 66
Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage
Logan, I. R., McNeill, H. V., Cook, S., Lü, X., Meek, D. W., Fuller-Pace, F. V., Lunec, J., & Robson, C. N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp180 · Cited by 68
Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion
Kim, J., Bae, S., An, S., Park, J. K., Kim, E. M., Hwang, S., Kim, W., & Um, H. (2014) · EMBO Reports · doi:10.15252/embr.201438587 · Cited by 66
hSSB1 regulates both the stability and the transcriptional activity of p53
Xu, S., Wu, Y., Chen, Q., Cao, J., Hu, K., Tang, J., Sang, Y., Lai, F., Wang, L., Zhang, R., et al. (2012) · Cell Research · doi:10.1038/cr.2012.162 · Cited by 68
da Costa, D. C. F., Fialho, E., & Silva, J. L. (2017) · Molecules · doi:10.3390/molecules22061014 · Cited by 68
Li, Z., Tanaka, M., Kataoka, H., Nakamura, R., Sanjar, R., Shinmura, K., & Sugimura, H. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0493-z · Cited by 66
Sato, T., Koseki, T., Yamato, K., Saiki, K., Konishi, K., Yoshikawa, M., Ishikawa, I., & Nishihara, T. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.528-534.2002 · Cited by 66
Calvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology · doi:10.1002/hep.24174 · Cited by 65
The p53/microRNA Network in Cancer: Experimental and Bioinformatics Approaches
Hünten, S., Siemens, H., Kaller, M., & Hermeking, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_5 · Cited by 66
Melchior, S., Codrich, M., Gorassini, A., Méhn, D., Ponti, J., Verardo, G., Tell, G., Calzolai, L., & Calligaris, S. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.136680 · Cited by 65
ATR mediates cisplatin resistance in a p53 genotype-specific manner
Sangster‐Guity, N., Conrad, B., Papadopoulos, N., & Bunz, F. (2011) · Oncogene · doi:10.1038/onc.2010.624 · Cited by 65
Self-citationRong, J., Hu, R., Song, X., Ha, J., Lu, N., Qi, Q., Tao, L., You, Q., & Guo, Q. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.016 · Cited by 65
Roles of p53 in Herpes Simplex Virus 1 Replication
Maruzuru, Y., Fujii, H., Oyama, M., Kozuka‐Hata, H., Kato, A., & Kawaguchi, Y. (2013) · Journal of Virology · doi:10.1128/jvi.01581-13 · Cited by 66
Rbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability
Jiang, Y., Zhang, M., Qian, Y., Xu, E., Zhang, J., & Chen, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524413 · Cited by 65
The molecular mechanism of G2/M cell cycle arrest induced by AFB1 in the jejunum
Yin, H., Jiang, M., Peng, X., Cui, H., Zhou, Y., He, M., Zuo, Z., Ouyang, P., Fan, J., & Fang, J. S. (2016) · Oncotarget · doi:10.18632/oncotarget.9594 · Cited by 65
Tran, T. Q., Gabra, M. B. I., Lowman, X. H., Yang, Y., Reid, M. A., Pan, M., O'Connor, T. R., & Kong, M. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002810 · Cited by 65
Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3
Wang, Y., Wu, S., Huang, C., Li, Y., Zhao, H., & Kasim, V. (2018) · Cancer Science · doi:10.1111/cas.13662 · Cited by 65
Takada, Y., Hachiya, M., Park, S., Osawa, Y., Ozawa, T., & Akashi, M. (2002) · PubMed · Cited by 65
Glick, A. B., Popescu, N. C., Alexander, V., Ueno, H., Böttinger, E. P., & Yuspa, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14949 · Cited by 65
Iwasa, T., Okamoto, I., Takezawa, K., Yamanaka, K., Nakahara, T., Kita, A., Koutoku, H., Sasamata, M., Hatashita, E., Yamada, Y., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605713 · Cited by 64
Endonuclease G: A role for the enzyme in recombination and cellular proliferation
Huang, K.-J., Ku, C., & Lehman, I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603445103 · Cited by 64
HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53
Hällgren, O., Gustafsson, L., Irjala, H., Selivanova, G., Orrenius, S., & Svanborg, C. (2006) · APOPTOSIS · doi:10.1007/s10495-006-3607-7 · Cited by 64
p53 Targets Simian Virus 40 Large T Antigen for Acetylation by CBP
Poulin, D. L., Kung, A. L., & DeCaprio, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8245-8253.2004 · Cited by 64
p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
Nozell, S. E., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205191 · Cited by 65
Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing
Pyo, C.-W., Choi, J. H., Oh, S.-M., & Choi, S.-Y. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.07.030 · Cited by 64
Chang, H.-L., Chen, C., Hsu, Y.-F., Kuo, W.-S., Ou, G., Chiu, P.-T., Huang, Y., & Hsu, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.011 · Cited by 68
Fischer, M., Grundke, I., Sohr, S., Quaas, M., Hoffmann, S., Knörck, A., Gumhold, C., & Rother, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063187 · Cited by 64
Identification of Tcf-4 as a transcriptional target of p53 signalling
Rother, K., Johne, C., Spiesbach, K., Haugwitz, U., Tschöp, K., Wasner, M., Klein‐Hitpaß, L., Möröy, T., Mössner, J., & Engeland, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207464 · Cited by 65
Combining chemotherapeutic agents and netrin‐1 interference potentiates cancer cell death
Paradisi, A., Creveaux, M., Gibert, B., Devailly, G., Redoulez, E., Neves, D., Cleyssac, E., Treilleux, I., Klein, C., Niederfellner, G. J., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302654 · Cited by 63
Metadata
- Authors
- Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
- Corresponding author
- Vogelstein, B.
- Venue
- Science
- Published
- 1998-11-20
- Volume
- 282
- Issue
- 5393
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080125477
- Cited by
- 2,803
- References
- 50
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
- FWCI
- 41.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
- MeSH terms
- Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review